Duchenne Muscular Dystrophy: everyone who lost the ability to walk had low Vitamin D (China)
Investigation of Walking Ability in 161 Patients With Duchenne Muscular Dystrophy
Clin Pediatr (Phila). 2026 doi: 10.1177/00099228261429136 PDF behind paywall
We aimed to identify modifiable risk factors affecting ambulation in Chinese children with Duchenne muscular dystrophy (DMD) by analyzing follow-up data from 161 patients with DMD. Continuous variables were compared using t-test or the Wilcoxon rank-sum test (for non-normally distributed variables). Cox regression determined factors influencing walking ability, and the log-rank test compared retention of walking ability between school-going and non-school-going patients. Hormone therapy (HR 3.72; P = .033), school attendance (HR 5.20; P = .010), and Disability and Social Support Rating Scale scores (HR 1.16; P = .021) significantly predicted loss of ambulation. Vitamin D levels were lower in ambulatory children with DMD who lost the ability to walk (F = 26.246, P = .000). Hormone therapy improved the 10-m walking time, while rehabilitation influenced the decumbent position and walking times. Early hormone therapy combined with consistent rehabilitation and school engagement is recommended for preserving ambulation.
Related in VitaminDWiki
- Muscular Dystrophy probably treated by high-dose Vitamin D plus muscle rehab
- Muscular Dystrophies – low vitamin D might be associated with all 9 types
- Magnesium helps muscles in more than 10 ways
- Muscle strength improved with Calfidediol (a form of vitamin D) - meta-analysis
perhaps this form would help Muscular Dystrophy as well - Skeletal Muscles regenerated with Vitamin D supplementation – review